National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 11456 [2015-04328]
Download as PDF
<![CDATA[
11456
Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993–
0002,Telephone: 301–796–1732, FAX:
301–796–9858, denise.picabranco@
fda.hhs.gov.
The first
day of the workshop will focus on
approaches for assessing the efficacy of
therapeutic products on neurocognitive
outcomes in patients diagnosed with
inborn errors of metabolism disorders.
The session will address the role of
natural history studies and
methodological approaches for selecting
appropriate assessment scales and
standardizing neurocognitive
assessments. The second day of the
workshop will discuss identification of
signals in animal studies and clinical
trials that warrant further clinical
investigation and testing that may be
predictive of neurocognitive outcome in
children. Additionally, strategies and
methods to address the challenges of
assessing long-term neurocognitive
outcomes for products used to treat
pediatric patients will be discussed.
Dated: February 24, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–04376 Filed 3–2–15; 8:45 am]
BILLING CODE 4164–01–P
SUPPLEMENTARY INFORMATION:
mstockstill on DSK4VPTVN1PROD with NOTICES
Participation in the Public Workshop
Registration: There is no fee to attend
the public workshop, but attendees
should register in advance. Space is
limited, and registration will be on a
first-come, first-served basis. Persons
interested in attending this workshop
must register online at neurocognitive_
workshop@fda.hhs.gov before March 31,
2015. For those without Internet access,
please contact Denise Pica-Branco (see
FOR FURTHER INFORMATION CONTACT) to
register. Onsite registration will not be
available.
If you need special accommodations
due to a disability, please contact
Denise Pica-Branco (see FOR FURTHER
INFORMATION CONTACT) at least 7 days in
advance.
Transcripts: Transcripts of the
workshop will be available for review at
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852, and at
https://www.regulations.gov
approximately 30 days after the
workshop. A transcript will also be
available in either hard copy or on CD–
ROM, after submission of a Freedom of
Information request. Send written
requests to the Division of Freedom of
Information (ELEM–1029), Food and
Drug Administration, 12420 Parklawn
Dr., Element Bldg., Rockville, MD
20857. Send faxed requests to 301–827–
9267.
VerDate Sep<11>2014
19:24 Mar 02, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Immunobiology of
Xenotransplantation (U01, U19).
Date: March 23–24, 2015.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3F100, 5601 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer,
Scientific Review Program, DEA/NIAID/NIH/
DHHS, 6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–496–3253,
nvazquez@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Mucosal Environment and
HIV Prevention (MEHP II (R01)).
Date: March 23–24, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3C100, 5601 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, Rockville, MD 20892, 240–669–
5036, Kelly.poe@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Innovative Assays to
Quantify the Latent HIV Reservoir (R01).
Date: March 26, 2015.
Time: 9:00 a.m. to 6:00 p.m.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
4F100, 5601 Fishers Lane, Rockville, MD
20892.
Contact Person: Jay R Radke, Ph.D., AIDS
Review Branch, Scientific Review Program,
DEA/NIAID/NIH/DHHS, Room 3G11B, 5601
Fishers Lane, Rockville, MD 20892, 240–669–
5046, jay.radke@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–04328 Filed 3–2–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Structure/Function studies of
Secondary Transporters in a Lipid
Environment.
Date: March 23–25, 2015.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Albert Wang, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4146, MSC 7806, Bethesda, MD
20892, 301–435–1016, wangca@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: March 24–25, 2015.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\03MRN1.SGM
03MRN1
]]>Agencies
[Federal Register Volume 80, Number 41 (Tuesday, March 3, 2015)]
[Notices]
[Page 11456]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Immunobiology of
Xenotransplantation (U01, U19).
Date: March 23-24, 2015.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3F100, 5601 Fishers
Lane, Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Nancy Vazquez-Maldonado, Ph.D., Scientific
Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-3253,
nvazquez@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Mucosal Environment and HIV
Prevention (MEHP II (R01)).
Date: March 23-24, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3C100, 5601 Fishers
Lane, Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D., Scientific Review Officer,
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane,
Rockville, MD 20892, 240-669-5036, Kelly.poe@nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Innovative Assays to Quantify the
Latent HIV Reservoir (R01).
Date: March 26, 2015.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 4F100, 5601 Fishers
Lane, Rockville, MD 20892.
Contact Person: Jay R Radke, Ph.D., AIDS Review Branch,
Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3G11B, 5601
Fishers Lane, Rockville, MD 20892, 240-669-5046, jay.radke@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-04328 Filed 3-2-15; 8:45 am]
BILLING CODE 4140-01-P
